Retinal Degeneration Fund
North America, North Carolina, United States, Raleigh
Description
Retinal Degeneration Fund makes mission-related investments in therapeutic companies with projects nearing clinical testing.
Investor Profile
Retinal Degeneration Fund has backed more than 12 startups, with 2 new investments in the last 12 months alone. The firm has led 4 rounds, about 33% of its total and boasts 1 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series A, Series B, Seed rounds (top funding stages).
- Majority of deals are located in United States, France.
- Strong thematic focus on Health Care, Therapeutics, Biotechnology.
- Led 1 rounds in the past year.
Stage Focus
- Series A (33%)
- Series B (33%)
- Seed (17%)
- Series Unknown (8%)
- Grant (8%)
Country Focus
- United States (92%)
- France (8%)
Industry Focus
- Health Care
- Therapeutics
- Biotechnology
- Pharmaceutical
- Life Science
- Genetics
- Biopharma
- Health Diagnostics
- Wellness
- Manufacturing
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
Who does Retinal Degeneration Fund frequently co-invest with?
What are some of recent deals done by Retinal Degeneration Fund?
Find More Investors Like Retinal Degeneration Fund
Discover similar investors in our database and build your perfect investor list.
Need help with your fundraising strategy?Read our fundraising guides
